Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Cell

• Publication date

  2013-05-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccr.2013.03.025PMID 23680151PMCID PMC3759356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA 1 and BRCA 2

  2015cited by this paper
• Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

  2012cited by this paper
• Advances in using PARP inhibitors to treat cancer

  2012cited by this paper
• Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells

  2012cited by this paper
• The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks

  2012influential reference
• Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1

  2012influential reference
• New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

  2012cited by this paper
• BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

  2011cited by this paper
• Poly(ADP-ribose) polymerase plays a differential role in DNA damage-response and cell death pathways in Trypanosoma cruzi.

  2011cited by this paper
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• PARP inhibitors in breast cancer: BRCA and beyond.

  2011cited by this paper
• RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci.

  2011cited by this paper
• BRCA1 and its toolbox for the maintenance of genome integrity

  2010cited by this paper
• PARP inhibition: PARP1 and beyond

  2010cited by this paper
• Double-strand DNA breaks recruit the centromeric histone CENP-A

  2009influential reference
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response

  2007cited by this paper
• Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length

  2007influential reference
• Poly(ADP-Ribose) Polymerase 1 Accelerates Single-Strand Break Repair in Concert with Poly(ADP-Ribose) Glycohydrolase

  2007cited by this paper
• Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

  2007cited by this paper
• RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.

  2007cited by this paper
• RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

  2007cited by this paper
• Positional stability of single double-strand breaks in mammalian cells

  2007cited by this paper
• RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.

  2007cited by this paper
• Crystal structure of the BARD1 BRCT domains.

  2007cited by this paper
• The DNA damage response: ten years after.

  2007cited by this paper
• Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase

  2007cited by this paper
• Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?

  2006cited by this paper
• Poly(ADP-ribose): novel functions for an old molecule

  2006cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

  2005cited by this paper
• Determination of intracellular concentrations of the TRPM2 agonist ADP-ribose by reversed-phase HPLC.

  2005cited by this paper
• Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

  2005influential reference
• Cardiac volume overload rapidly induces oxidative stress-mediated myocyte apoptosis and hypertrophy.

  2005cited by this paper
• The BRCA1 RING and BRCT Domains Cooperate in Targeting BRCA1 to Ionizing Radiation-induced Nuclear Foci*

  2005cited by this paper
• Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1

  2004cited by this paper
• Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

  2004cited by this paper
• The macro domain is an ADP‐ribose binding module

  2004influential reference
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer

  2004cited by this paper
• The BRCT Domain Is a Phospho-Protein Binding Domain

  2003influential reference
• Mutational analysis of BARD1 in familial breast cancer patients in Japan.

  2003cited by this paper
• BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting

  2003cited by this paper
• Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks

  2003cited by this paper
• Phosphopeptide Binding Specificities of BRCA1 COOH-terminal (BRCT) Domains*

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Spatial and Temporal Cellular Responses to Single-Strand Breaks in Human Cells

  2003cited by this paper
• Identification of Residues Required for the Interaction of BARD1 with BRCA1*

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death

  2001cited by this paper
• Human placenta hydrolases active on free ADP-ribose: an ADP-sugar pyrophosphatase and a specific ADP-ribose pyrophosphatase.

  2001cited by this paper
• Physiology and pathophysiology of poly(ADP‐ribosyl)ation *

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• In search of the tumour-suppressor functions of BRCA1 and BRCA2

  2000cited by this paper
• Mapping the Functional Domains of BRCA1

  1999cited by this paper
• Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

  1999influential reference
• BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair*

  1999cited by this paper
• Studies on the ADP-ribose Pyrophosphatase Subfamily of the Nudix Hydrolases and Tentative Identification of trgB, a Gene Associated with Tellurite Resistance*

  1999cited by this paper
• XRCC1 Is Specifically Associated with Poly(ADP-Ribose) Polymerase and Negatively Regulates Its Activity following DNA Damage

  1998cited by this paper
• Stimulation of the DNA-dependent Protein Kinase by Poly(ADP-Ribose) Polymerase*

  1998cited by this paper
• A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability

  1998cited by this paper
• Immunodot blot method for the detection of poly(ADP-ribose) synthesized in vitro and in vivo.

  1998cited by this paper
• The genetics of breast cancer susceptibility.

  1998cited by this paper
• Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.

  1998cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• BRCA1 protein products ... Functional motifs...

  1996cited by this paper
• Specific ADP-ribose pyrophosphatase from Artemia cysts and rat liver: effects of nitroprusside, fluoride and ionic strength.

  1996cited by this paper
• …Functional motifs…

  1996cited by this paper
• Inhibition and ADP-ribose pyrophosphatase-I by nitric-oxide-generating systems: a mechanism linking nitric oxide to processes dependent on free ADP-ribose.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• High resolution fractionation and characterization of ADP-ribose polymers.

  1993cited by this paper
• A specific, low K m ADP‐ribose pyrophosphatase from rat liver

  1989cited by this paper
• The BRCT Domain Is a PhosphoProtein Binding Domain

  year unknowninfluential reference

• Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation.

  2026cites this paper
• Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage.

  2025cites this paper
• BRCA2 prevents PARPi-mediated PARP1 retention to protect RAD51 filaments

  2025cites this paper
• Multiple functions of PARP1 in the repair of DNA double strand breaks.

  2025cites this paper
• Captain Tardigrade and Its Shield to Protect DNA

  2025cites this paper
• BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview

  2025cites this paper
• PARP1: A comprehensive review of its mechanisms, therapeutic implications and emerging cancer treatments.

  2025cites this paper
• Stronger preference of human tumor suppressor protein BRCA1 for an open-planar Holliday junction: Insights from a combined spectroscopic and computational study.

  2025cites this paper
• Novel clinical potential of poly (ADP‑ribose) polymerase inhibitors in triple‑negative breast cancer: Mechanistic insights and clinical applications (Review)

  2025influential citation
• Distinct mechanisms of recognition of phosphorylated RNAPII C-terminal domain by BRCT repeats of the BRCA1–BARD1 complex

  2025cites this paper
• Retinoic acid-induced 2 deficiency impairs genomic stability in breast cancer

  2025cites this paper
• Saturation genome editing of BARD1 resolves VUS and provides insight into BRCA1-BARD1 tumor suppression

  2025influential citation
• BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

  2025cites this paper
• Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

  2025cites this paper
• Germline BARD1 Mutation in High-Risk Chinese Breast and Ovarian Cancer Patients

  2025cites this paper
• Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer

  2025cites this paper
• Engineered chromatin readers track damaged chromatin dynamics in live cells and animals

  2025cites this paper
• Development of a liquid overlay-based three-dimensional cell culture panel for drug screening applications

  2025cites this paper
• "Yin-Yang" of PARP1 in genotoxic and inflammatory response.

  2025cites this paper
• BRCA1 and BRCA2 in DNA damage and replication stress response: Insights into their functions, mechanisms, and implications for cancer treatment.

  2025cites this paper
• Melatonin alleviates UV-induced embryonic toxicity via PARP1 expression in early mouse embryos.

  2025cites this paper
• Research progress on the fanconi anemia signaling pathway in non-obstructive azoospermia

  2024cites this paper
• Apoptotic vesicles are required to repair DNA damage and suppress premature cellular senescence

  2024cites this paper
• Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer

  2024cites this paper
• The role of rRNA in maintaining genome stability.

  2024cites this paper
• A review of poly(ADP-ribose)polymerase-1 (PARP1) role and its inhibitors bearing pyrazole or indazole core for cancer therapy.

  2024cites this paper
• DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair

  2024cites this paper
• Interaction of RECQL4 with poly(ADP‐ribose) is critical for the DNA double‐strand break response in human cells

  2024cites this paper
• BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks.

  2024cites this paper
• SPIN1 facilitates chemoresistance and HR repair by promoting Tip60 binding to H3K9me3

  2024cites this paper
• PARP1-TRIM44-MRN loop dictates the response to PARP inhibitors

  2024influential citation
• PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair

  2024cites this paper
• Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia

  2024cites this paper
• PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy

  2024cites this paper
• APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance

  2024cites this paper
• Functional Analysis of BARD1 Missense Variants on Homology‐Directed Repair in Ovarian and Breast Cancers

  2024cites this paper
• The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors

  2023cites this paper
• Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)

  2023cites this paper
• Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage

  2023cites this paper
• PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance.

  2023cites this paper
• Oxidative DNA Damage-induced PARP-1-mediated Autophagic Flux Disruption Contributes to Bupivacaine-induced Neurotoxicity During Pregnancy

  2023cites this paper
• The BRCA1/BARD1 complex recognizes pre-ribosomal RNA to facilitate homologous recombination

  2023cites this paper
• Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer

  2023cites this paper
• The Impact of NAD Bioavailability on DNA Double-Strand Break Repair Capacity in Human Dermal Fibroblasts after Ionizing Radiation

  2023cites this paper
• Profiling the metabolome of uterine fluid for early detection of ovarian cancer

  2023cites this paper
• HDAC-an important target for improving tumor radiotherapy resistance

  2023cites this paper
• Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

  2023cites this paper
• An inventory of crosstalk between ubiquitination and other post-translational modifications in orchestrating cellular processes

  2023cites this paper
• Identification of BRCC3 and BRCA1 as Regulators of TAZ Stability and Activity

  2023cites this paper
• Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?

  2023cites this paper
• Fatty acid oxidation facilitates DNA double-strand break repair by promoting PARP1 acetylation

  2023cites this paper
• Opinion: PARP inhibitors in cancer—what do we still need to know?

  2022cites this paper
• A Double-Edged Sword: The Two Faces of PARylation

  2022cites this paper
• A sePARate phase? Poly(ADP-ribose) versus RNA in the organization of biomolecular condensates

  2022cites this paper
• Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair

  2022cites this paper
• A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination.

  2022cites this paper
• Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity

  2022cites this paper
• BARD1 mystery: tumor suppressors are cancer susceptibility genes

  2022influential citation
• Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors

  2022cites this paper
• Protein post-translational modifications in the regulation of cancer hallmarks

  2022cites this paper
• Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy

  2022cites this paper
• Computational structural assessment of BReast CAncer type 1 susceptibility protein (BRCA1) and BRCA1-Associated Ring Domain protein 1 (BARD1) mutations on the protein-protein interface.

  2022cites this paper
• A field guide to the proteomics of post‐translational modifications in DNA repair

  2022cites this paper
• BRCA1 and DNA damage response

  2022cites this paper
• The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.

  2022cites this paper
• Platinum-based systematic therapy in triple-negative breast cancer.

  2022cites this paper
• BARD1 is an ATPase activating protein for OLA1.

  2022cites this paper
• Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies

  2022cites this paper
• Pre-ribosomal RNA reorganizes DNA damage repair factors in nucleus during meiotic prophase and DNA damage response

  2022cites this paper
• Veliparib for the treatment of solid malignancies

  2022cites this paper
• Immediate-Early, Early, and Late Responses to DNA Double Stranded Breaks

  2022cites this paper
• BRCA1/BARD1 is a nucleosome reader and writer.

  2022cites this paper
• Roles for the methyltransferase SETD8 in DNA damage repair

  2022influential citation
• Exceptional behavior of breast cancer-associated type 1 gene in breast invasive carcinoma

  2022cites this paper
• In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern

  2022cites this paper
• The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy

  2022influential citation
• RNAi Screening Uncovers a Synthetic Sick Interaction between CtIP and the BARD1 Tumor Suppressor

  2022cites this paper
• BRCA1 Antibodies Matter

  2021cites this paper
• Breast Cancer Treatments: Updates and New Challenges

  2021cites this paper
• Is it a wrap? Nucleosome interactions of the BRCA1-binding partner, BARD1, steal the scene

  2021cites this paper
• Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability

  2021cites this paper
• The Tardigrade Damage Suppressor Protein Promotes Transcription Factor Activation and Expression of DNA Repair Genes in Human Cells in Response to Hydroxyl Radicals and UV-C Exposure

  2021influential citation
• The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells

  2021cites this paper
• Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.

  2021cites this paper
• RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage

  2021cites this paper
• SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation

  2021cites this paper
• POGZ modulates the DNA damage response in a HP1-dependent manner

  2021cites this paper
• Untangling the crosstalk between BRCA1 and R-loops during DNA repair

  2021cites this paper
• A synergetic effect of BARD1 mutations on tumorigenesis

  2021cites this paper
• UbiNet 2.0: a verified, classified, annotated and updated database of E3 ubiquitin ligase–substrate interactions

  2021cites this paper
• Mechanisms of BRCA1–BARD1 nucleosome recognition and ubiquitylation

  2021cites this paper
• Inhibition of poly (ADP-Ribose) polymerase: A promising strategy targeting pancreatic cancer with BRCAness phenotype

  2021cites this paper
• With Our Powers Combined

  2021cites this paper
• Decreased expression of the translation factor eIF3e induces senescence in breast cancer cells via suppression of PARP1 and activation of mTORC1

  2021cites this paper
• Progress in reversible ADP- ribosylation modification in DNA damage repair and cancer treatment

  2021cites this paper
• The Tardigrade Damage Suppressor Protein Modulates Transcription Factor and DNA Repair Genes in Human Cells Treated with Hydroxyl Radicals and UV-C

  2021influential citation
• Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in Morocco

  2021cites this paper
• BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination

  2021cites this paper
• POGZ promotes homology‐directed DNA repair in an HP1‐dependent manner

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper